
Metoprolol
Metoprolol lowers blood pressure and heart rate and, in large trials, improved survival in heart failure (extended-release form) and after a heart attack. Starting it in the first hours of an acute heart attack did not lower deaths in a large trial, and starting high-dose extended-release metoprolol just before noncardiac surgery led to more deaths and strokes in another. For supplements, the main concerns are stimulants that push the other way (energy drinks), herbs and foods that lower blood pressure further (hawthorn, celery seed, cocoa), and CBD, which blocks the enzyme that clears metoprolol in lab studies.
Prescription medication: not a dietary supplement
This is an FDA-approved (or investigational) drug, not a supplement. It requires a prescription and medical supervision. The information below summarizes clinical-trial evidence for education only. It is not a recommendation to obtain or use it without a doctor.
Quick decision guide
May help most
Adults with high blood pressure, angina, heart failure with reduced ejection fraction, or a past heart attack, treated and monitored by a prescriber
Common dosing range
Set by your prescriber. Toprol-XL (succinate) starts at 25 to 100 mg once daily for blood pressure and 12.5 or 25 mg for heart failure; metoprolol tartrate usually starts at 100 mg a day for blood pressure, in one or two doses
When to expect effects
Heart rate falls within hours; the label says the full blood pressure effect of a dose level shows after about 1 week. Survival benefit in heart failure appeared within about a year in MERIT-HF
Watch out for
Do not stop metoprolol suddenly: the labels warn that abrupt stopping can worsen angina and, in some cases, cause a heart attack, and say to taper over 1 to 2 weeks with a prescriber. It can slow the heart too much, especially with digoxin, diltiazem, verapamil or clonidine, and it can hide the fast heartbeat that warns of low blood sugar
What is it
Metoprolol is a prescription beta-blocker used for high blood pressure, angina (chest pain from narrowed heart arteries), heart failure, and after a heart attack. It comes in two forms that are not interchangeable dose for dose: metoprolol tartrate, an immediate-release tablet usually taken twice a day (brand Lopressor), and metoprolol succinate, an extended-release tablet or capsule taken once a day (brands Toprol-XL and Kapspargo Sprinkle). It is "cardioselective": at usual doses it acts mainly on the beta-1 receptors of the heart. Its level in the blood depends on the liver enzyme CYP2D6, so some antidepressants and other drugs that block that enzyme can raise it.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
survival in heart failure with reduced ejection fraction Good Evidence | About 34 percent fewer deaths over about 1 year | Adults with symptomatic heart failure and an ejection fraction of 40 percent or less, stable on standard treatment | Within months; the trial lasted a mean of 1 year |
survival after a heart attack Good Evidence | 36 percent fewer deaths at 3 months | Adults after a heart attack whose blood pressure and heart rhythm are stable | Within 3 months |
early intravenous then oral metoprolol in acute heart attack Good Evidence | No difference in deaths; fewer repeat heart attacks offset by more cardiogenic shock | Not applicable | Assessed over up to 4 weeks in hospital |
starting extended-release metoprolol before noncardiac surgery Good Evidence | Fewer heart attacks but more deaths (hazard ratio 1.33) and strokes (2.17) | Not applicable | Assessed over 30 days |
blood pressure Limited Evidence | About 10/8 mmHg lower blood pressure than placebo for the drug class | Adults with high blood pressure who also have angina, heart failure or a past heart attack | About 1 week for the full effect of a dose level |
survival in heart failure with reduced ejection fraction
- Effect
- About 34 percent fewer deaths over about 1 year
- Best fit
- Adults with symptomatic heart failure and an ejection fraction of 40 percent or less, stable on standard treatment
- Time
- Within months; the trial lasted a mean of 1 year
survival after a heart attack
- Effect
- 36 percent fewer deaths at 3 months
- Best fit
- Adults after a heart attack whose blood pressure and heart rhythm are stable
- Time
- Within 3 months
early intravenous then oral metoprolol in acute heart attack
- Effect
- No difference in deaths; fewer repeat heart attacks offset by more cardiogenic shock
- Best fit
- Not applicable
- Time
- Assessed over up to 4 weeks in hospital
starting extended-release metoprolol before noncardiac surgery
- Effect
- Fewer heart attacks but more deaths (hazard ratio 1.33) and strokes (2.17)
- Best fit
- Not applicable
- Time
- Assessed over 30 days
blood pressure
- Effect
- About 10/8 mmHg lower blood pressure than placebo for the drug class
- Best fit
- Adults with high blood pressure who also have angina, heart failure or a past heart attack
- Time
- About 1 week for the full effect of a dose level
Evidence for 5 uses
AI-assisted evidence assessment. Talk to your doctor before relying on any single supplement.
survival in heart failure with reduced ejection fraction
Disease adjunctMERIT-HF randomized 3,991 people with chronic heart failure (NYHA class II to IV, ejection fraction 40 percent or less), already on standard therapy, to extended-release metoprolol succinate (target 200 mg once daily) or placebo. The trial was stopped early after a mean of 1 year. Deaths from any cause were 7.2 versus 11.0 percent per patient-year (relative risk 0.66), with fewer sudden deaths (79 versus 132) and fewer deaths from worsening heart failure (30 versus 58). Trials stopped early can overstate benefit. The result applies to the extended-release succinate form studied, not to heart failure with preserved ejection fraction.
Bottom line: In one large trial, extended-release metoprolol cut deaths by about a third in heart failure with reduced ejection fraction.
survival after a heart attack
Disease adjunctIn the Goteborg trial, 1,395 patients with definite or suspected heart attack received metoprolol (15 mg intravenously, then 100 mg by mouth twice daily) or placebo for 90 days, starting soon after arrival in hospital. There were 40 deaths (5.7 percent) on metoprolol versus 62 (8.9 percent) on placebo, a 36 percent reduction. This trial supports the labeled use of metoprolol tartrate after a heart attack in patients whose circulation is stable. It was done before modern reperfusion and statin treatment.
Bottom line: One trial found fewer deaths in the 3 months after a heart attack with metoprolol.
early intravenous then oral metoprolol in acute heart attack
No benefit foundCOMMIT randomized 45,852 people at 1,250 hospitals within 24 hours of a suspected heart attack to metoprolol (up to 15 mg intravenously, then 200 mg a day by mouth) or placebo for up to 4 weeks in hospital. Deaths did not differ (7.7 versus 7.8 percent), nor did the combined rate of death, repeat heart attack or cardiac arrest (9.4 versus 9.9 percent). Metoprolol prevented about 5 repeat heart attacks and 5 cases of ventricular fibrillation per 1,000 treated, but caused about 11 more cases of cardiogenic shock per 1,000, mostly in the first day or so and in people whose circulation was unstable. The authors suggest starting a beta-blocker in hospital once the patient is stable.
Bottom line: Very early, high-dose metoprolol in acute heart attack did not lower deaths and raised shock risk.
starting extended-release metoprolol before noncardiac surgery
No benefit foundPOISE randomized 8,351 people with or at risk of artery disease, not already on a beta-blocker, to extended-release metoprolol succinate (100 mg started 2 to 4 hours before noncardiac surgery, then 200 mg a day for 30 days) or placebo. Heart attacks fell (4.2 versus 5.7 percent), but deaths rose (3.1 versus 2.3 percent) and strokes roughly doubled (1.0 versus 0.5 percent). This is why the labels say not to start a high-dose extended-release regimen before noncardiac surgery. It does not apply to people already taking metoprolol, whom the labels say should not routinely stop it before surgery.
Bottom line: Starting high-dose metoprolol just before surgery caused more harm than good.
blood pressure
Biomarker supportA Cochrane review of 56 short trials (3 to 12 weeks, 7,812 people with mild to moderate high blood pressure) found that beta-1 selective blockers, including metoprolol, lowered blood pressure by an average of 10/8 mmHg and heart rate by 11 beats per minute versus placebo; the reviewers rated this evidence low quality. The largest drop came at about twice the starting dose. A separate Cochrane review of outcome trials, in which three-quarters of beta-blocker users took atenolol rather than metoprolol, found beta-blockers as first treatment for high blood pressure reduced strokes but not deaths compared with placebo, and did less well than calcium channel blockers. Blood pressure is a marker; most outcome data on metoprolol come from heart failure and heart attack trials.
Bottom line: Metoprolol lowers blood pressure, but beta-blockers protect less against stroke than some other blood pressure drugs.
How it works
How to take it
What to track
Bottom line: A prescriber sets the dose and the form. Take it regularly, never stop it suddenly, and check new antidepressants, heart drugs and CBD with your pharmacist.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
Stopping suddenly can worsen angina and, in some cases, trigger a heart attack. The labels say to reduce the dose gradually over 1 to 2 weeks under a prescriber's care, including in people treated only for high blood pressure. (Current FDA labels list this as a warning, not a boxed warning.)
Slow heart rate, including sinus pause, heart block and cardiac arrest; the risk is higher with existing conduction problems or other drugs that slow the heart
Worsening heart failure, especially while the dose is being increased
Narrowing of the airways (bronchospasm) in people with asthma or similar lung disease, because beta-1 selectivity is not absolute
Low blood sugar: beta-blockers can hide warning signs such as a fast heartbeat and raise the risk of severe or prolonged lows, especially in people with diabetes, children, and anyone fasting, not eating regularly or vomiting
Other label warnings: it can hide signs of an overactive thyroid, and stopping suddenly can trigger a thyroid storm; it can worsen poor circulation in the legs; and people with severe allergies may not respond to usual doses of epinephrine
Who should avoid it
- People with severe bradycardia, second- or third-degree heart block, sick sinus syndrome without a permanent pacemaker, cardiogenic shock or decompensated heart failure: contraindicated
- People with a past allergic reaction to metoprolol or the product's ingredients: contraindicated
- People with asthma or other bronchospastic disease, in general: the labels allow use at the lowest possible dose only when other treatments fail or are not tolerated
- People with a pheochromocytoma, unless an alpha-blocker has been started first
Pregnancy & breastfeeding
Pregnancy: the labels say published observational studies have not shown a higher risk of major birth defects, miscarriage or other harms with metoprolol, but there are inconsistent reports of restricted fetal growth, preterm birth and perinatal death with beta-blockers, from studies with important limitations. Metoprolol crosses the placenta, and newborns may have low blood pressure, low blood sugar, a slow heart rate or breathing problems, so they should be observed. Untreated high blood pressure and heart failure also carry risks in pregnancy. Breastfeeding: metoprolol passes into breast milk in small amounts (an estimated 0.05 mg to under 1 mg a day for the infant, 0.5 to 2 percent of the mother's weight-adjusted dose), no adverse effects in breastfed infants have been identified, and the labels advise watching the baby for a slow heart rate and other signs of beta-blockade. If you are pregnant, planning a pregnancy or breastfeeding, talk to your doctor.
Interactions
Energy drinks push heart rate and blood pressure up, the opposite of what metoprolol does. In a crossover trial in 34 healthy young adults, drinking 32 oz of an energy drink within an hour raised blood pressure and lengthened the QTc interval of the heart rhythm more than placebo (by up to about 18 to 20 ms versus 12 ms). No study has tested energy drinks in people taking metoprolol; one case report described a young woman on bisoprolol, another beta-blocker, who drank several energy drinks a day and had a rapid heart rhythm that was hard to correct. Avoiding them is the cautious choice; review your caffeine use with your doctor or pharmacist.
The labels say these drugs doubled metoprolol concentrations, and higher levels reduce metoprolol's heart selectivity; weaker CYP2D6 blockers may also raise levels. The labels advise close monitoring when the combination cannot be avoided. Ask your pharmacist to check any new antidepressant or heart rhythm medicine.
These drugs also slow the heart's electrical conduction and heart rate, so combining them with metoprolol raises the risk of a dangerously slow pulse. With clonidine, the labels say the beta-blocker should be stopped several days before clonidine is gradually withdrawn, because metoprolol can worsen the rebound rise in blood pressure. Your prescriber plans any changes to these combinations.
The labels for Kapspargo Sprinkle and generic metoprolol succinate extended-release capsules say alcohol makes the capsule release metoprolol faster, which may increase the risk of side effects, and tell patients to avoid alcohol. The evidence is a lab dissolution test: about 89 percent of the dose was released within 2 hours in 40 percent alcohol, and about 17 percent in 5 percent alcohol; no study in people has measured the effect. The Toprol-XL tablet and metoprolol tartrate labels say nothing about alcohol, so check which form you take and ask your doctor what they advise about drinking.
In human liver enzyme studies, CBD was a potent blocker of CYP2D6, the enzyme that clears metoprolol, and the labels say strong CYP2D6 blockers double metoprolol levels; whether everyday CBD doses do this in people has not been tested. A single 600 mg dose of CBD also lowered resting systolic blood pressure by 6 mmHg in 9 healthy men, though it raised their heart rate. Tell your prescriber if you use CBD and watch for dizziness, fainting or an unusually slow pulse.
Hawthorn has a mild blood-pressure-lowering effect that can add to metoprolol's. In 79 people with type 2 diabetes, 71 percent of whom took blood pressure medicines, 1,200 mg of hawthorn extract daily for 16 weeks lowered diastolic pressure slightly more than placebo (from 85.6 to 83.0 versus 84.5 to 85.0 mmHg), and no herb-drug interaction was found. In a 2-year trial in 2,681 people with heart failure on standard medicines, side effects with hawthorn extract were similar to placebo. No study has tested hawthorn with metoprolol specifically; review it with your doctor or pharmacist and report dizziness on standing.
Celery contains 3-n-butylphthalide and other compounds that relax blood vessels. In 52 people with high blood pressure, celery seed extract (1.34 g a day for 4 weeks) lowered 24-hour systolic pressure from 141.2 to 130.0 mmHg, with no change on placebo. That trial used a seed extract; celery juice has not been tested this way. Regular use could add to metoprolol's effect, so check your home readings and review it with your doctor or pharmacist.
The labels say these drugs may add to metoprolol's effect, and patients should be watched for low blood pressure or a marked slowing of the heart, which can cause vertigo, fainting or dizziness on standing.
In a 1977 laboratory study of heart mitochondrial enzymes, metoprolol inhibited CoQ10-dependent enzymes less than propranolol did. This was a test-tube finding: whether metoprolol lowers CoQ10 levels in people, or whether CoQ10 changes metoprolol's effect on blood pressure or heart rate, has not been established. No harmful interaction is known; mention CoQ10 to your doctor or pharmacist if you take it.
Beta-blockers can lower the body's own nighttime melatonin: in 15 healthy volunteers, the beta-blocking forms of propranolol and atenolol cut nighttime melatonin output by 80 to 86 percent (metoprolol was not tested in that study). In a 3-week trial in 16 people with high blood pressure taking atenolol or metoprolol, nightly melatonin increased total sleep by 36 minutes and helped them fall asleep 14 minutes sooner than placebo. If metoprolol disturbs your sleep, raise it with your prescriber, and tell them if you use melatonin.
This is an additive, usually helpful effect rather than a harmful clash. A Cochrane review of 35 trials found flavanol-rich cocoa lowered blood pressure by about 2 mmHg on average, and systolic pressure by about 4 mmHg in people with high blood pressure, over 2 to 18 weeks. A steady, modest intake is unlikely to matter; if you start a concentrated cocoa flavanol supplement, watch your home readings and report dizziness.
Documented interactions
Evidence-graded pair pages with sources, dosing notes, and timing guidance, a complement to the narrative section above.
Warnings (4)
+ alcohol
moderateThe labels for metoprolol succinate extended-release capsules (Kapspargo Sprinkle and its generic capsule) say alcohol makes the capsule release metoprolol faster, which may increase the risk of side effects, and tell patients to avoid alcohol. The evidence is a lab dissolution test: about 89 percent of the dose was released within 2 hours in 40 percent alcohol, and about 17 percent in 5 percent alcohol; no study in people has measured the effect. The Toprol-XL extended-release tablet and metoprolol tartrate tablet labels say nothing about alcohol.
+ hawthorn
moderateHawthorn (Crataegus) extract lowers blood pressure slightly and may add to metoprolol's blood-pressure lowering. In a 16-week randomized trial in 79 people with type 2 diabetes, 71 percent of whom took blood pressure medicines, 1,200 mg a day lowered diastolic pressure slightly more than placebo, and no herb-drug interaction was found. In heart failure, where metoprolol is often used, results are mixed: in the 2,681-person SPICE trial, adverse events with hawthorn were similar to placebo, while in the 120-person HERB CHF trial more adverse events were reported with hawthorn, and a follow-up analysis found a higher risk of early heart failure worsening. No study has tested hawthorn with metoprolol itself.
+ coq10
lowIn a 1977 laboratory study, several beta-blockers inhibited a CoQ10-dependent mitochondrial enzyme of the heart; metoprolol was a weaker inhibitor than propranolol, and timolol had almost no effect. Whether metoprolol lowers CoQ10 levels in people, and whether that causes fatigue or is relieved by CoQ10 supplements, has not been established. No harmful interaction between the two is known.
+ melatonin
lowBeta-blockers such as metoprolol suppress the body's own nighttime melatonin, which may explain the insomnia some people report on them. In a randomized trial in 16 people with high blood pressure taking atenolol or metoprolol, nightly melatonin for 3 weeks increased total sleep by 36 minutes and shortened the time to fall asleep, without rebound sleep problems when it was stopped. This is a low-concern combination: no study has shown harm from using the two together.
Choosing a product
What to look for on the label, and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Can I drink energy drinks or coffee while taking metoprolol?⌄
Energy drinks are best avoided: in a trial of healthy young adults, a large energy drink raised blood pressure and changed the heart's electrical rhythm, working against what metoprolol does. Metoprolol itself has not been tested with energy drinks. Talk with your doctor or pharmacist about how much caffeine is reasonable for you, and check your pulse and blood pressure at home.
Is CBD safe with metoprolol?⌄
It is not proven safe or unsafe. In lab studies CBD strongly blocks CYP2D6, the enzyme that breaks down metoprolol, and drugs that block that enzyme can double metoprolol levels. CBD can also lower blood pressure. Tell your prescriber if you use it, and report dizziness, fainting or an unusually slow pulse.
Can I take hawthorn or celery seed with metoprolol?⌄
Both have mild blood-pressure-lowering effects that can add to metoprolol's. Small trials found modest drops in blood pressure and no obvious harm, but none tested them with metoprolol specifically. Review them with your doctor or pharmacist before starting, and watch your home readings for lows or dizziness on standing.
Can melatonin help if metoprolol affects my sleep?⌄
Beta-blockers can lower the body's own nighttime melatonin, and in a small 3-week trial of people taking atenolol or metoprolol, 2.5 mg of melatonin at night improved sleep compared with placebo. Discuss it with your prescriber first, because poor sleep can have other causes and your medicine plan may need review.
What is the difference between metoprolol tartrate and metoprolol succinate?⌄
Tartrate (such as Lopressor) is immediate release and usually taken twice a day with or right after meals. Succinate (such as Toprol-XL or Kapspargo Sprinkle) is extended release and taken once a day; the extended-release form was the one shown to improve survival in heart failure. They are not interchangeable without your prescriber, so check that the form on your bottle matches what was prescribed.
Can I stop metoprolol if I feel fine?⌄
Do not stop it on your own. The labels warn that stopping suddenly can worsen chest pain and, in some cases, cause a heart attack, even in people taking it only for blood pressure. If you want to stop or change it, your prescriber will reduce the dose gradually over 1 to 2 weeks.
References by claim
survival in heart failure with reduced ejection fraction
PMID 10376614 · PubMed (1999) link
survival after a heart attack
Hjalmarson et al., 1981 · PubMed (1981) link
early intravenous then oral metoprolol in acute heart attack
Chen et al., 2005 · PubMed (2005) link
starting extended-release metoprolol before noncardiac surgery
Devereaux et al., 2008 · PubMed (2008) link
Safety
Interaction: Energy drinks
Interaction: Alcohol (extended-release capsules)
Interaction: CBD (cannabidiol)
Interaction: Hawthorn
Interaction: Celery juice and celery seed extract
Shayani Rad et al., 2022 · PubMed (2022) link
Interaction: Coenzyme Q10 (CoQ10)
Kishi et al., 1977 · PubMed (1977) link
Interaction: Melatonin
Interaction: Dark chocolate and cocoa flavanols
Ried et al., 2017 · PMC (2017) link
Track Metoprolol with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora app.
Disclaimer: This page summarizes published clinical-trial data for educational purposes and is not medical advice or a recommendation to use this prescription medication. Dosing, eligibility, and monitoring must be decided by a licensed prescriber.
